None
Quote | First Trust Amex Biotech Index Fund (NYSE:FBT)
Last: | $153.08 |
---|---|
Change Percent: | 0.01% |
Open: | $152.37 |
Close: | $153.08 |
High: | $153.13 |
Low: | $151.835 |
Volume: | 13,317 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | First Trust Amex Biotech Index Fund (NYSE:FBT)
2024-07-03 22:30:00 ET Summary Closing out the first half of 2024, the S&P 500 Total Return Index (which includes dividend reinvestment) is up an incredible +15.3%. According to Apollo asset management, Nvidia accounted for a record-breaking 34.5% of the total return in the S&...
2024-07-03 08:00:00 ET Summary The economy underneath has been very strong, and that’s really what’s enabled the Fed to actually push out those interest rate cuts. The best performing sector has been technology with all of the AI powering the technology gains. Th...
Message Board Posts | First Trust Amex Biotech Index Fund (NYSE:FBT)
Subject | By | Source | When |
---|---|---|---|
wow, this is a bricksnick house! | Fibanotch | investorshub | 08/21/2018 4:57:22 PM |
News, Short Squeeze, Breakout and More Instantly...
First Trust Amex Biotech Index Fund Company Name:
FBT Stock Symbol:
NYSE Market:
2024-07-01 10:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 11:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-11 12:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...